CSIMarket
 
Somalogic Inc   (SLGC)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

A loss of $-0.18 per Share at SLGC during the July to September 30 2022 time-frame

company announced third quarter of 2022 operating deficit of $-40.612 millions


Published Nov 16 2022
CSIMarket Team / CSIMarket.com


dna-163466__340 company announced very solid Revenue improvement of 108.648 % year on year to $41.71 millions in the third quarter of 2022 earnings season, but lost money at $-0.18.

compared to the preceding financial reporting period advanced loss from $-0.13 per share and Revenue doubled by 194.917 % from $14.14 millions.


In the July to September 30 2022 time-frame Somalogic Inc reported net loss of $-32.942 million, instead of deficit of $-41.419 millions in the comparable financial reporting period a year ago.


Somalogic Inc is expected to report next financial earnings on May 15, 2023.



Somalogic Inc's Free Cash Flow Margin

Somalogic Inc's Receivables Turnover Ratio



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com